Zilver PTX RCT mortality analysis: no difference in long-term mortality rate for Zilver PTX drug-eluting stent compared to PTA/BMS
CVIR Endovasc
.
2019 Jul 27;2(1):25.
doi: 10.1186/s42155-019-0069-x.
Authors
Michael D Dake
1
,
Gary M Ansel
2
,
Aaron E Lottes
3
Affiliations
1
The University of Arizona, Tucson, AZ, USA. mddake@email.arizona.edu.
2
Department of Medicine, Ohio Health / Riverside Methodist Hospital, Columbus, OH, USA.
3
Cook Research Incorporated, West Lafayette, IN, USA.
PMID:
32027000
PMCID:
PMC6966343
DOI:
10.1186/s42155-019-0069-x
No abstract available
Publication types
Letter